Nanoparticles have the potential to revolutionize current bio-medical diagnostic and therapeutic methods. For example, magnetic nanoparticles with unique superparamagnetism are emerging as next-generation probes for high performance magnetic resonance (MR) imaging. Their enhanced properties and nanoscale controllability in terms of size, composition, surface states, and magnetic spin structure have allowed for the highly sensitive and target-specific MR imaging of various biological systems including cancer detection, cell trafficking, and angiogenesis. On the other hand, viruses can be utilized as excellent delivery vehicles due to their facile cellular transfection and gene expression efficacies within their target cells. Such excellent properties of viruses offer promising prospects for gene therapy of genetic diseases and cancers, as well as for the genetic engineering of cells. Despite these prospects, a lack of understanding of their biological behaviors including in vivo migration, molecular recognition, gene delivery, and ultimate fate following their desired biofunctional applications limits their further development. There have been previous studies in the development of nanoparticle probing systems for viruses including virus-gold and virus-quantum dot nanoparticle systems. However, their utilization in the probing of viral gene delivery has not been investigated so far. Recently, Gd-based MR contrast agent-coated viruses were developed, but their functional behaviors including targetrecognition, cellular transfection, and gene delivery capabilities have not been demonstrated partly due to the intrinsically low sensitivity of Gd-based MR contrast agents. Our strategy is to hybridize the virus with magnetic nanoparticles into a single nanoparticle system with the dual-functional capabilities of target-specific MR imaging and gene delivery. Specifically, we fabricate hybrid nanoparticles of “enhanced green fluorescent protein (eGFP) promoter genecontaining adenovirus” and “manganese-doped magnetism engineered iron oxide (abbreviated as MnMEIO) nanoparticle”. As the viral gene delivery vector, we selected adenoviruses. Adenoviruses are known to be highly effective for transferring double-stranded DNAs to various cell types. Along with a gene delivery capability, adenoviruses possess targetspecificity to the cells with overexpression of Coxsackievirus B adenovirus receptor (CAR) which is known to facilitate the binding and intrusion of adenoviruses to the host cells. As the magnetic nanoparticle component we selected manganese-doped magnetism-engineered iron oxide (MnFe2O4, MnMEIO) nanoparticles, since it is known that MnMEIO exhibits exceptional MR contrast effects (R2 (=1/T2) value of 358 sec mM) and therefore is advantageous as probes for ultra-sensitive MR imaging. Briefly, the thermal reaction of manganese chloride (MnCl2) and iron tris(2,4-pentadionate) in hot organic solvents containing oleic acid and oleylamine capping molecules yielded hydrophobically capped MnMEIO nanoparticles. Their water-solubility and biocompatibility were attained by introducing 2,3-dimercaptosuccinic acids to the nanoparticle surface. Nanoparticles obtained were 12 nm with a high sizemonodispersity (r < 7%) and possessed single crystallinity, and a saturation magnetization value of 110 emu g (Mn+Fe). Hybridization of adenoviruses with MnMEIO nanoparticles was performed through a slight modification of a literature method, as follows. First, the capsid lysine residues of the adenoviruses were converted to maleimide groups by reacting them with sulfo-succinimidyl(4-N-maleimidomethyl)cyclohexane-1-carboxylate (sulfo-SMCC) cross-linkers. These groups were allowed to react with a large stoichiometric amount of MnMEIO nanoparticles, which resulted in the formation of adenovirus-MnMEIO hybrid nanoparticles by way of the nucleophilic addition of a surface thiol group of MnMEIO to the C O M M U N IC A IO N